TL: BIOSAFETY PROTOCOL - Press Advisory 1 SO: Greenpeace International, (GP) DT: May, 1998 International rules needed to control proliferation of genetically engineered organisms Like any new technology, the use of genetic engineering needs to be controlled. The international community is only now learning to understand the complexities inherent in this new technology. Unfortunately the products have superseded the legislation. In September 1997 the US Environmental Protection Agency approved the use of a soil bacteria called Rhizobia which has been genetically engineered to make plants grow more vigorously by providing them nitrogen. GE Rhizobia bacteria was approved to be used in 3 million acres (1.2 million hectares) this year. There are however several problems with GE Rhizobia. Even if the bacteria worked as planned, it would benefit weeds which would grow more vigorously. But the bacteria can also go terribly wrong by rendering soil infertile by outcompeting its natural counterparts. Furthermore the genetically engineered Rhizobia carries two antibiotic resistance genes which may be transferred to other bacteria. One of these genes gives resistance against streptomycin which has become increasingly useful for the treatment of tuberculosis due to resistance building against other antibiotics. The most alarming aspect of the soil bacteria is that it can be distributed by water or e.g. carried away on the soles of shoes. It may almost certainly get transferred across national boundaries. So the US EPA has given a de facto global authorisation for a genetically altered bacteria that can persist in soil for many years. GE Rhizobia approval reveals the potential risks and legal problems of genetic engineering. On May 4-15 1998 the world's Environment Ministers will gather in Bratislava, Slovakia at the Fourth Conference of Parties to the Convention on Biological Diversity (CBD). Part of the negotiation is a time table for the regulation on the proliferation of genetically engineered organisms. This regulation is known as "the Biosafety Protocol". What is the Biosafety Protocol? Over 170 governments have so far signed the CBD. Article 19 of the Convention includes a proposal for a protocol regulating transfer, handling and use of genetically modified organisms (GMOs). In November 1995, at the 2nd Conference of Parties in Jakarta, it was decided to establish a negotiation process for a biosafety protocol. The negotiations are taking place in the Open-ended Ad Hoc Working Group on Biosafety which has met four times since 1996. At the Fourth Conference of Parties of the CBD in Bratislava a time line for the negotiations will be set. Greenpeace's concerns What is known about genetic engineering is that it is a risky business. Once released, GMOs may survive, multiply and spread, causing irreversible damage to web of life and interdependency between species. The large-scale growing of genetically engineered crops may place biological diversity at risk as a result of gene flow from GE crops to their wild relatives. The hybridisation of the GMO varieties with their wild relatives is also likely to lead to the loss or permanent alteration of the wild species. This is only one of several problems related to genetic engineering. Given the risks already known about releasing GMOs into the environment, let alone what is not yet known about the long-term negative environmental impacts, Greenpeace considers that the precautionary principle must a basis for any decisions on evaluating risks to biological diversity. In the absence of scientific certainty about the effects of GMOs they cannot be considered safe. Greenpeace considers that the release and use of GMOs creates unnecessary and high risks for the environment for which full responsibility must be taken. Rules to allocate liability and compensation in the event of damage would provide incentives for environmentally responsible actions. They would also be consistent with the current trend of applying the "polluter pays" principle. To-date, OECD countries at the Biosafety negotiations have refused to accept the inclusion in the Biosafety Protocol of guiding principles to allocate responsibility and compensation for the damaged caused by GMOs. Greenpeace is calling on the world's governments participating in Biosafety Protocol meetings to produce a strong, internationally binding agreement to protect biodiversity and human health from the risks of releasing GMOs into the environment. Greenpeace's demands for a Biosafety Protocol The Biosafety Protocol must contain strong, legally binding rules to regulate the entire life cycle of GMOs and products containing GMOs. The precautionary principle must be the general objective for the Biosafety Protocol. There must be an unambiguous right for countries to reject imports, exports and movement across their territories of GMOs. All exporting countries should establish systems of segregation and certification to ensure traceability, transparency and consumer choice. International rules establishing civil and state liability and compensation need to be included in the Biosafety Protocol to deal with harm caused by GMOs. There should be a moratorium on international trade in GMOs and GMO-products until the Biosafety Protocol enters into force. Mika Railo press officer Greenpeace International tel: +31-(0)20-5249 548 mobile: +31-(0)6- 535 04 721 fax: +31-20-5236 212 email: mika.railo@ams.greenpeace.org